Kathryn Emily Colombo Pugh

Title: Kathryn Emily Colombo Pugh: Innovator in Pharmaceutical Compositions

Introduction

Kathryn Emily Colombo Pugh is a notable inventor based in Bend, OR (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating cancer. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to improving healthcare.

Latest Patents

Kathryn holds a patent for "Pharmaceutical compositions and dosage forms." This patent relates to pharmaceutical compositions comprising N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)-benzamide and a polymer. The patent also includes dosage forms comprising the formulation and methods of treating subjects having cancer. This innovative approach highlights her commitment to advancing medical treatments.

Career Highlights

Kathryn is currently associated with Ignyta, Inc., where she continues to work on groundbreaking pharmaceutical research. Her role at the company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to cancer treatment.

Collaborations

Some of her notable coworkers include Robert L. Orr and Matthew Jarud Shaffer. Their collaboration fosters a dynamic environment for innovation and research, contributing to the success of their projects.

Conclusion

Kathryn Emily Colombo Pugh is a remarkable inventor whose work in pharmaceutical compositions is making a difference in cancer treatment. Her patent and ongoing research at Ignyta, Inc. reflect her dedication to improving healthcare outcomes.